Name: Tonix Pharmaceuticals Holding Corp. (TNXP) Balance Sheet
Creator: FinSpry

Tonix Pharmaceuticals Holding Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Tonix Pharmaceuticals Holding Corp. (TNXP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	98.78	24.95	120.23	178.66	77.07	11.25	25.03
Cash & Short-Term Investments	98.78	24.95	120.23	178.66	77.07	11.25	25.03
Accounts Receivable	3.68	6.10	8.04	7.73	0.00	0.00	0.53
Inventory	8.41	14.15	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.73	2.57	9.32	9.21	9.26	0.00	0.00
Total Current Assets	119.00	47.77	130.78	189.05	87.99	13.95	26.06
Non-Current Assets
Property, Plant & Equipment (Net)	42.82	94.85	94.53	51.47	9.83	0.39	0.04
Long-Term Investments	0.90	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	0.00	0.97	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.12	9.74	0.12	0.00	0.12	0.00	0.00
Other Non-Current Assets	0.95	1.13	0.26	0.38	0.25	0.10	0.10
Total Non-Current Assets	43.89	106.69	94.91	51.85	10.19	0.61	0.26
Total Assets	162.89	154.46	225.69	240.90	98.18	14.56	26.32
Current Liabilities
Accounts Payable	4.55	3.78	8.07	21.23	4.60	4.78	1.57
Short-Term Debt	2.82	2.35	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	2.82	2.35	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	3.66	3.74	9.68	7.95	4.63	0.00	0.00
Deferred Revenue	1.82	2.98	3.27	2.83	0.00	0.00	0.00
Other Current Liabilities	0.70	1.40	0.66	0.67	0.00	0.00	0.00
Total Current Liabilities	18.31	18.88	18.18	21.72	9.82	5.14	2.66
Non-Current Liabilities
Long-Term Debt	4.67	6.56	0.33	0.47	0.72	0.01	0.00
Other Non-Current Liabilities	0.00	22.86	0.00	0.00	34.60	14.60	0.00
Total Non-Current Liabilities	5.03	30.05	0.33	0.47	0.72	0.01	0.00
Total Liabilities	23.33	48.93	18.51	22.18	10.54	5.14	2.66
Stockholders' Equity
Common Stock	0.00	0.00	0.01	0.02	0.21	0.00	0.00
Retained Earnings	-730.69	-600.66	-470.04	-359.91	-267.53	-217.12	-188.45
Accumulated Other Comprehensive Income	-0.26	-0.23	-0.17	-0.09	-0.06	0.00	-0.04
Additional Paid-in Capital	870.50	706.42	677.38	578.61	355.04	226.52	212.16
Shares Outstanding	4.39	0.02	0.00	0.00	0.00	0.00	0.00
Total Stockholders' Equity	139.56	105.53	207.18	218.72	87.65	9.42	23.66
Total Liabilities & Equity	162.89	154.46	225.69	240.90	98.18	14.56	26.32